A Agilent Technologies Inc.

Agilent Presents Thought Leader Award to Dr. Stéphane Bayen

(NYSE: A) today announced that has received an Agilent Thought Leader Award. Dr. Bayen is an Associate Professor in the Department of Food Science and Agricultural Chemistry at in Montreal, Quebec, Canada.

This press release features multimedia. View the full release here:

Dr. Stéphane Bayen, Associate Professor, Department of Food Science and Agricultural Chemistry, McGill University (Photo: Business Wire)

Dr. Stéphane Bayen, Associate Professor, Department of Food Science and Agricultural Chemistry, McGill University (Photo: Business Wire)

The award will support Dr. Bayen’s research contributions to analytical techniques and the development of reliable and robust workflows to identify honey authenticity using non-targeted chemical fingerprinting strategies.

Regarded as the next-generation surveillance approach for chemicals in food, non-targeted analysis using high-resolution mass spectrometry coupled with innovative software enables the rapid characterization of thousands of chemicals in complex food matrices such as honey.

“Honey is one of the top adulterated foods in the world,” said Mary McBride, associate vice president, Applied Markets and Regulations, Laboratory Solutions Marketing at Agilent, and executive sponsor of the award. “This award will help create routine and reliable non-targeted fingerprinting methods to ensure not only the authenticity of honey but its safety for consumers.”

“High-resolution mass spectrometry allows us to map food components in an unprecedented fashion,” said Dr. Bayen. “This approach will revolutionize the way we manage and regulate food quality, food safety, and food authenticity.”

Food authenticity testing utilizing chemical fingerprinting strategies is emerging as a more effective approach to track food fraud, and chemical fingerprints are virtually impossible to imitate due to their complexity.

The Agilent Thought Leader Award program promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics, and chemical analysis space. To learn more, visit the web site.

About Agilent Technologies

Agilent is a leader in life sciences, diagnostics, and applied chemical markets, delivering innovative technology solutions that provide trusted answers to researchers’ most challenging scientific questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on , , and .

EN
14/06/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Key facts and statistics - fiscal 2025

A summary company profile, detailing Agilent Technologies, Inc.’s business operations and financial highlights.

Agilent Technologies, Inc. - October 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch